Join the Class Action: Protect Your Rights with Agenus Inc.
In the ever-changing landscape of the stock market, investors often find themselves in challenging situations, particularly when it comes to understanding their rights. For those who purchased stocks of Agenus Inc. (NASDAQ: AGEN) between January 23, 2023, and July 17, 2024, there is an important call to action underway that could significantly impact your investments.
Why Now is the Time to Act
The Rosen Law Firm, recognized as a leader in investor rights, reminds investors of the crucial date approaching—November 5, 2024. This deadline is critical for those who wish to join the securities class action lawsuit against Agenus. If you were part of the investor group during the specified periods, you may be eligible for compensation without incurring out-of-pocket expenses, thanks to a contingency fee agreement.
The Importance of Legal Representation
Understanding the ins and outs of securities law can be daunting, which is why securing qualified counsel is essential. Rosen Law Firm stands out due to its proven track record of success, particularly in securities class actions. Unlike many firms that merely act as middlemen, Rosen Law firmly litigates cases on behalf of its clients, ensuring that their rights are vigorously defended.
The Firm's Accomplishments
The firm's commitment to its clients is evidenced by its record achievements, including the largest ever securities class action settlement against a Chinese company. In 2017, it was ranked No. 1 by ISS Securities Class Action Services for the number of settlements achieved, a position it has maintained in the top ranks every year since 2013. In 2019 alone, it secured over $438 million for investors, highlighting its effectiveness in pursuing justice for its clients.
Understanding the Case Details
The case against Agenus stems from allegations made throughout the class period. Accusations include misleading statements about the efficacy of its combination therapy involving botensilimab and balstilimab. These products are intended for serious health conditions but may have been misrepresented, leading to substantial investor losses when the truth became known. Understanding these details is vital for any investor who might be affected.
Your Next Steps
To join the action, it is important to make your voice heard quickly. For those interested, you can visit the Rosen Law Firm’s website or contact them directly to gather more information about how to proceed with your claim. If you want to serve as a lead plaintiff, you must act promptly, as the court requires action by the upcoming deadline. By participating, you not only advocate for your own rights but also for those of fellow investors facing similar challenges.
Staying Informed
Remaining updated with the latest developments is crucial. Investors are encouraged to follow reputable sources or connect with the Rosen Law Firm through their social media platforms. Here, you can receive constant updates about the case, the legal process, and any new information that may emerge.
Conclusion
Investing is always a risk but has the potential for reward. However, in instances where misleading information affects your investments, knowing your rights is paramount. Agenus Inc. stockholders from the class period should feel empowered to take action and seek legal representation that prioritizes their needs. Don’t let the opportunity slip by—protect your investment rights today!
Frequently Asked Questions
What is the class action about?
The class action targets misleading statements made by Agenus regarding its therapy effectiveness, potentially impacting investors.
What is the deadline for joining the class action?
The deadline to join the class action is November 5, 2024.
Who can join the class action?
Any investor who purchased Agenus Inc. stocks between January 23, 2023, and July 17, 2024, can join.
What compensation can I expect?
You may be entitled to compensation without upfront fees through a contingency fee agreement.
How do I get more information?
For detailed information, you can contact the Rosen Law Firm directly via email or phone.
